Drug for rare lung cancer receives FDA approval
CANCER DIGEST – Jan. 7, 2023 – The US FDA has approved a new treatment for a rare type of lung cancer following a clinical trial led by...
Men over 70 undergoing low-value prostate cancer screening
CANCER DIGEST – Jan. 4, 2023 – An analysis of Medicare data shows that men over 70 may be undergoing unnecessary prostate cancer...
Parkinson's drug may substantially reduce chemo side effects
CANCER DIGEST – Dec. 3, 2022 – Researchers have found that a drug already FDA-approved for treatment of Parkinson’s disease may reduce...
New immunotherapy approach promises to improve cancer outcomes
CANCER DIGEST – Nov. 19, 2022 – Researchers at Albert Einstein College of Medicine have identified an additional protein cancer cells use...
CT screening for early lung cancer leads to long-term survival
CANCER DIGEST – Nov. 27, 2022 – A new study shows that early detection of lung cancer with CT scanning dramatically increases long-term...
Metastasis-directed therapy may prolong progression-free survival in prostate cancer
CANCER DIGEST – Nov. 12, 2022 – For patients with prostate cancer that has spread to a single site outside the prostate, a therapy...
